Hepatitis C Diagnosis and Management

Understanding HCV Titer vs. Antibody Testing

The Centers for Disease Control and Prevention recommends quantitative nucleic acid tests (NATs) to measure the actual amount of virus circulating in the blood, reported as IU/mL, which is critical for monitoring treatment effectiveness 1, 2
Modern quantitative HCV RNA assays have a lower detection limit of 12-15 IU/mL and an upper limit of 7-8 log IU/mL, according to the Clinical and Molecular Hepatology guidelines 3
The viral load measurement is critical for monitoring treatment effectiveness, but it does NOT correlate with disease severity or stage of liver fibrosis, as stated by the MMWR Recommendations and Reports 1, 2

Viral load is essential for confirming active infection in anti-HCV positive patients, and serves as a baseline measurement before treatment initiation, as recommended by the Journal of Hepatology 4, 5, 6
Quantitative HCV RNA is the definitive marker for treatment response and cure (sustained virological response = undetectable HCV RNA 12 weeks post-treatment), according to the Hepatology guidelines 6
Viral load does not predict disease severity, degree of liver inflammation, or stage of fibrosis, as stated by the MMWR Recommendations and Reports 1, 2

The diagnostic algorithm for HCV testing should follow this sequence: first-line test anti-HCV antibody, followed by reflex to quantitative HCV RNA testing if anti-HCV positive, as recommended by the Journal of Hepatology and Hepatology 4, 5, 6
Interpretation of test results: anti-HCV positive + HCV RNA detected = Active chronic infection requiring treatment, according to the Journal of Hepatology 4, 5

In acute hepatitis C, HCV RNA becomes detectable as early as 1-2 weeks after infection, while antibodies appear at 8-9 weeks on average, as stated by the Clinical and Molecular Hepatology and MMWR Recommendations and Reports 3, 9
For patients with anti-HCV positive but HCV RNA negative results, repeat RNA testing in 3 months if ongoing risk factors exist or recent exposure is suspected, as recommended by the Journal of Hepatology 4, 5